Gastroparesis Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies – Relamorelin, Tradipitant, Velusetrag, NG101

 Breaking News
  • No posts were found

Gastroparesis Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies – Relamorelin, Tradipitant, Velusetrag, NG101

October 26
08:04 2022
Gastroparesis Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies - Relamorelin, Tradipitant, Velusetrag, NG101
The Gastroparesis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Gastroparesis pipeline products will significantly revolutionize the Gastroparesis market dynamics.

DelveInsight’s “Gastroparesis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Gastroparesis, historical and forecasted epidemiology as well as the Gastroparesis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Gastroparesis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

To Know in detail about the Gastroparesis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Gastroparesis Market Insights

 

Gastroparesis Overview

Gastroparesis, which is a translated meaning of “stomach paralysis”, is a digestive disorder characterized by delayed gastric emptying of solid food in the absence of mechanical obstruction of the stomach, resulting in the cardinal symptoms of early satiety, postprandial fullness, nausea, vomiting, belching, and bloating.

 

Some of the key facts of the Gastroparesis Market Report: 

  • The Gastroparesis market size was valued at USD 3,219.82 Million in 2020 and is anticipated to grow with a significant CAGR during the study period (2019-2032) 
  • The Total prevalent population of gastroparesis in the 7MM was 34,243,119 cases in 2020. These cases of gastroparesis in the 7MM 
  • As per estimates, the highest prevalence of gastroparesis was observed in the United States with 13,306,122 cases in 2020 
  • Key Gastroparesis Companies: Allergan, Vanda Pharmaceuticals, Theravance Biopharma, Neurogastrx, and others
  • Key Gastroparesis Therapies: Relamorelin, Tradipitant, Velusetrag, NG101, and others 
  • The Gastroparesis epidemiology based on gender analyzed that a higher percentage of prevalence of Gastroparesis was observed for females, in comparison to males, in all the 7MM countries 

 

Get a Free sample for the Gastroparesis Market Report 

 

Key benefits of the Gastroparesis Market report:

  1. Gastroparesis market report covers a descriptive overview and comprehensive insight of the Gastroparesis Epidemiology and Gastroparesis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Gastroparesis market report provides insights on the current and emerging therapies.
  3. Gastroparesis market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Gastroparesis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Gastroparesis market.

 

Download the report to understand which factors are driving Gastroparesis epidemiology trends @ Gastroparesis Epidemiological Insights 

 

Gastroparesis Market  

The dynamics of the Gastroparesis market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.

 

Gastroparesis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Gastroparesis Epidemiology Segmentation:

The Gastroparesis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Gastroparesis
  • Prevalent Cases of Gastroparesis by severity
  • Gender-specific Prevalence of Gastroparesis
  • Diagnosed Cases of Episodic and Chronic Gastroparesis

 

Gastroparesis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gastroparesis market or expected to get launched during the study period. The analysis covers Gastroparesis market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Gastroparesis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Gastroparesis market share @ Gastroparesis market forecast 

 

Gastroparesis Therapies and Key Companies

  • Relamorelin: Allergan
  • Tradipitant: Vanda Pharmaceuticals
  • Velusetrag: Theravance Biopharma
  • NG101: Neurogastrx

 

Gastroparesis Market Drivers

  • Dynamic Gastroparesis Pipeline
  • Emerging Biomarkers and Targets
  • Rising Prevalence of Diabetes

 

Scope of the Gastroparesis Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Gastroparesis Companies: Allergan, Vanda Pharmaceuticals, Theravance Biopharma, Neurogastrx, and others
  • Key Gastroparesis Therapies: Relamorelin, Tradipitant, Velusetrag, NG101, and others
  • Gastroparesis Therapeutic Assessment: Gastroparesis current marketed and Gastroparesis emerging therapies
  • Gastroparesis Market Dynamics:  Gastroparesis market drivers and Gastroparesis market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Gastroparesis Unmet Needs, KOL’s views, Analyst’s views, Gastroparesis Market Access and Reimbursement 

 

Gastroparesis Market Barriers

  • Lack of Clinical Evidence by Prescription Drugs
  • Economic Burden
  • Failure of Therapies

 

Table of Contents 

1. Gastroparesis Market Report Introduction

2. Executive Summary for Gastroparesis

3. SWOT analysis of Gastroparesis

4. Gastroparesis Patient Share (%) Overview at a Glance

5. Gastroparesis Market Overview at a Glance

6. Gastroparesis Disease Background and Overview

7. Gastroparesis Epidemiology and Patient Population

8. Country-Specific Patient Population of Gastroparesis 

9. Gastroparesis Current Treatment and Medical Practices

10. Gastroparesis Unmet Needs

11. Gastroparesis Emerging Therapies

12. Gastroparesis Market Outlook

13. Country-Wise Gastroparesis Market Analysis (2019–2032)

14. Gastroparesis Market Access and Reimbursement of Therapies

15. Gastroparesis Market Drivers

16. Gastroparesis Market Barriers

17.  Gastroparesis Appendix

18. Gastroparesis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Gastroparesis treatment, visit @ Gastroparesis Medications

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV 89107
Country: United States
Website: https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market

Related Articles

Calendar

December 2022
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Categories